Stonepine Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Stonepine Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-38,597	Closed	-$2.52M	–	61
2025 Q2	$2.52M	Sell	38,597 -9,403	-20%	-$612K	2.48%	13
2025 Q1	$13.6M	Buy	48,000 +27,600	+135%	+$1.65M	13.28%	1
2024 Q4	$1.13M	Buy	+20,400	New	+$1.17M	0.91%	28
2022 Q3	–	Sell	-28,800	Closed	-$854K	–	20
2022 Q2	$854K	Buy	28,800 +2,740	+11%	+$79K	0.4%	23
2022 Q1	$733K	Sell	26,060 -26,230	-50%	-$978K	0.3%	26
2021 Q4	$2.41M	Buy	+52,290	New	+$2.25M	1.11%	19
2016 Q2	–	Sell	-1,650	Closed	-$56K	–	24
2016 Q1	$56K	Buy	+1,650	New	+$56K	0.07%	17

Other funds holding ANIP

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return